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 Abstract 
Aim Attention Deficit Hyperactivity Disorder (ADHD) is a lifespan disorder associated with 
considerable economic cost. While the economic burden of ADHD has been widely 
estimated, there is considerable variation in reported costs between studies, which typically 
focus on health outcomes only, lack adequate control and fail to correct for the influence of 
genetic and shared environmental factors. The aim of this study is to overcome these 
limitations to reach a fuller understanding of the economic burden of ADHD. 
Method Using the Danish National Registers 5269 adults with a diagnosis of ADHD in 
adulthood who had not received a diagnosis in childhood were identified. Excluding cases 
with missing data, comorbid diagnoses, and cases without a same sex sibling free of any 
diagnosed psychiatric diagnoses, a final cohort was formed consisting of 460 sibling dyads. 
Using a cross-sectional method focusing on the year 2010, cost differences between each 
adult with ADHD and their sibling were calculated from data retrieved from health, 
education, crime, employment and social care registers.  
Results Adults with ADHD had considerably lower disposable income and paid less tax than 
their siblings. They also received more state benefits, had higher costs for health, social care, 
and crime than their siblings. The total average costs difference for the year 2010 was 20,134 
euros more than their sibling for each adult with ADHD. 
Conclusion ADHD is associated with considerable costs which are borne by both the 
individual and the state and underlines the need to consider the wider economic impact of 
ADHD beyond income and healthcare utilisation costs. 
 
This study was supported by a grant from the Rockwool Foundation. 
Introduction 
 Attention Deficit Hyperactivity Disorder (ADHD) is a lifespan disorder[1]
 
associated with a 
considerable psychological[2] and cost burden[3] and was included in the global burden of 
diseases study in 2010, but the limitation of sparse data lead to widespread uncertainty 
intervals around the burden estimates[4]. The lifetime prevalence of ADHD is now widely 
acknowledged[5], and
 
while
 
some studies suggest that ADHD in adulthood may be different 
to ADHD in childhood[6], recent evidence finds little support for late onset adult ADHD[7]. 
Differences between early and later onset for ADHD may simply reflect different 
developmental trajectories of environmental exposure and experience [7, 8]. Meta-analyses 
have demonstrated that the economic burden of ADHD impacts on different outcomes for 
adults and children, with much greater costs in adulthood than in childhood[9]. For adults, the 
greatest cost burden is productivity and income losses (($87B-$138B), but for children, the 
largest cost categories are health care ($21B-$44B) and education ($15B-$25B)[9]. However, 
cost estimates vary considerably between studies[10] which cloud the understanding of the 
true cost burden. Variations can chiefly be attributed to a number of important 
methodological limitations: i) Few studies examining the costs of ADHD explore costs 
beyond direct medical expenses[11], ii) Only a minority include costs to the criminal justice 
system[2] as most are dependent upon reanalysis of existing insurance company databases 
which usually hold information on health variables only[9], iii) While the few longitudinal 
studies available are free to explore a wider range of cost outcomes they have very small 
sample sizes, especially at follow-up[2], and struggle to control for the impact of 
comorbidity, diagnosis and service use on reported costs[12], iv) Most studies utilise poor 
control or comparison groups, often involving non-affected individuals or heterogeneous 
clinical groups with potentially overlapping difficulties[13]
 
or national estimates that fail to 
control for genetic or shared environmental factors between individuals and groups [9]. 
While the influence of shared environment on the expression of ADHD is controversial[14, 
15], the influence of shared environment on factors which are known to drive cost differences 
between individuals such as anti-social behavior [16] and educational attainment [17] have 
been clearly demonstrated. 
 
The aim of this study is to overcome the limitations of the current literature and to reach a 
fuller understanding of the social and individual economic impact of ADHD.  The study taps 
into the Danish population based registers[18]. The key focus is to study the costs of 
untreated ADHD in adults diagnosed with ADHD in adulthood who did not receive a 
diagnosis in childhood, and where costs are uncontaminated by treatment in childhood. The 
study investigates the extent to which individuals with undiagnosed ADHD in childhood, 
adolescence and early adulthood fare differently compared to their same sex siblings without 
ADHD, controlling for comorbidity in both groups as comorbidities such as autism, or 
depression are often associated with considerable economic disadvantage and allows 
clinicians and policy makers to distinguish the cost of ADHD in adulthood from the costs 
associated with co-morbidity.  The advantage of this sibling-based analysis is that it offers a 
high level of control for sociodemographic and childhood factors, as siblings share similar 
genetic and environmental backgrounds which have usually gone unobserved, or undetected, 
in traditional cost analyses[16, 17] Focusing on individuals who received a diagnosis in 
adulthood but not childhood also removes the need for complex cost corrections to remove 
the impact of treatment in childhood on costs in adulthood. It also provides healthcare 
systems with a better estimate of the cost of ADHD uncontaminated by treatment effects. 
Methods 
Design 
The cross-sectional method was employed to calculate costs for the year 2010 which was the 
latest year for which full data was available at the time of application to access the data from 
Statistics Denmark.  
Study population 
The study population was identified using the unique Danish Civil Registration System 
(CRS) [19]. The CRS is continuously updated and contains detailed data on all Danish 
residents. The system includes a personal identification number (PIN) which is also used in 
every other population-based register in Denmark, thus enabling accurate linkage between 
registers (e.g., linking siblings). 
 
A total of 5269 individuals with ADHD were identified, who received at least one of five 
International Classification of Diseases, 10
th
 Revision (ICD-10)[20] Hyperkinetic (ADHD) 
diagnoses (F90.0, F90.1, F90.8, F90.9, F98.8) between 1995 and 2010 and who were between 
18 and 50 years of age at the time of diagnosis. Following exclusion of cases with missing 
values, comorbid diagnoses and cases without a same sex sibling free of any psychiatric 
diagnosis, the final study population consisted of 460 dyads.  
All data was anonymized by and obtained through a strict application procedure overseen by 
Statistics Denmark. According to Danish legislation, register-based studies involving 
anonymized data do not require informed consent. 'We attest that we have obtained 
appropriate permissions and paid any required fees for use of copyright protected materials. 
 
A comparison of the 460 Adults with ADHD and no other psychiatric disorders, against the 
entire Danish adult population without any registered psychiatric diagnosis is presented in 
table 1. This analysis clearly shows significant differences across all categories with the 
exception of in-patient hospital care which was still higher in the ADHD group. These 
differences may be due to variations in developmental age, experience or opportunity, and 
underline the need for the sibling comparison analysis adopted for this study.  This 
comparison was based on estimates of the differences between the Adult ADHD group and 
their same sex siblings, excluding the influence from comorbidity by removing dyads where 
individuals with ADHD had a registered co-morbid psychiatric diagnosis, or where the 
sibling had any registered psychiatric diagnosis. This sibling-based matched control group 
offers a high level of control for shared genetic and socio-demographic factors, including 
upbringing [21]. It presents an enhanced econometric method to reduce the risk of 
unobserved differences in costs between the two groups[14, 17, 22] (see Fig. 1). 
 
Data sources  
We identified adults with a diagnosis of ADHD through the Danish National Patient 
Register[22] (DNPR) and Danish Psychiatric Central Research Register[23] (DPCR), an 
electronic register containing information on every psychiatric admission from 1969 onwards 
as well as outpatient treatment and psychiatric accident and emergency department contacts 
included from 1995. Psychiatrists in private practice and General  
 
Practitioners (GP’s) are not required to register psychiatric patient data in the Danish national 
registers. Thus, the registers contain psychiatric data on patients referred to and diagnosed in 
hospital-based in- and outpatient services only. A recent study has demonstrated that the 
recorded diagnoses of ADHD in the Danish registers are reliable [24]
. 
We obtained personal information on individuals identified with ADHD and their siblings 
concerning health-care, educational attainment, labor market performance, crime, traffic 
accidents, health care, foster care from a record linkage of the following Danish population 
based registers[18]: The Danish National Patient Register[19] including the Danish 
Psychiatric Central Register[23],
 
The Student Register[25],  The Danish Central Crime 
Register[26], The Traffic Accident Register, The Income Statistics Register[27], The 
Integrated Database for Labor Market Research (IDA)[28], The National Sickness Benefit 
Register[27], and the National Prescription Registry[29]. 
 
[Insert figure 1 and table 1 around here] 
Analysis strategy 
Cost differences between adults with ADHD and their same sex siblings were estimated 
using the following strategy. First, the same sex sibling closest in age to the individual with 
ADHD was selected. Second, the mean outcome measures for the treatment group and the 
matched sibling control groups were compared. Third, it was determined whether the mean 
differences were significantly different from zero using t-tests.    
 
Individual or family borne costs of ADHD refer to all costs incurred by individuals including 
loss of income moderated by gains in income replacement transfers (net income taxes), 
individual costs of being a victim of a crime, and private costs of prescription medicine. 
Public or societal costs of ADHD are all costs paid by local or central Government including 
income transfers, loss of income taxes, cost of crime, education,  
 
traffic accidents and publicly provided health care, including subsidies for prescription 
medicine. The social costs of ADHD are the total costs and are defined as the sum of both 
individual/family borne and public/societal costs.  
 
When calculating the costs of ADHD, the prevalence-based method has been used, where 
costs from individuals from a single year are calculated (in this case 2010). The cross-
sectional prevalence based method was employed, as it makes the best use of data [30]
 
and 
because the group of adults with ADHD, with its relatively small share of individuals above 
the age of 35, was simply not mature enough to make good life-cycle estimates. The costs 
reported are interpreted as average yearly costs of ADHD. The monetary cost measures used 
in the calculations come from a variety of sources. Some are measured directly in monetary 
terms, for example personal income and tax. Others are measured in shares or crude numbers, 
for example for GP visits where the number of visits are counted and multiplied by the unit 
cost to arrive at the economic impact. For foster care costs, we only include costs for those in 
foster care after the age of 18 years of age. See Daley et al.[31] for more details about cost 
difference calculations.  Throughout this analysis we present our cost results in Euros using a 
standard exchange rate of 7.45 Danish Kroner to the Euro.  
Results 
Table 2 shows the results from the sibling analysis and the unit costs used in the calculation. 
For almost all the cost elements the difference between the ADHD-groups and the sibling 
control groups is significantly different from zero. Particularly large differences can be seen 
for receipt of social security benefit and early retirement benefit, but the differences in 
personal income and the number of GP contacts between Adults with ADHD and their same 
sex siblings are remarkable.   
[Insert table 2 around here] 
 
 
An examination of table 3 demonstrates the cost differences for the adult ADHD sample 
compared against the sibling comparison group. Negative values indicate greater costs for the 
Adult ADHD group and positive values indicate greater costs for the siblings. A focus on 
individual costs (which fall to the individual) indicate that adults with ADHD have 
considerably less disposable income than their siblings, as well as higher personal medication 
costs. A focus on public/societal costs (which fall to the state) demonstrates that adults with 
ADHD receive more state income subsidies and pay less tax thea their siblings, are associated 
with higher costs for, crime and medical costs (inpatient, general practice and medication). 
An examination of the relative costs reveals the striking differences in disposable income 
between siblings with and without ADHD as well as the fact that cost differences between 
siblings with and without ADHD for crime related cost were comparable to the cost 
differences for health care utilization.  Total average cost differences between Adults with 
ADHD and their sibling were 20,135 euros per individual with ADHD, per year. An 
examination of Fig. 2 presents the same cost differences as easier to access percentage data 
and highlight the relative differences for individual cost categories between adults with 
ADHD and their siblings. An examination of Fig. 2 highlights the very high relative cost 
differences between Adults with ADHD and their siblings, especially for personal income, 
prescribed medication and social welfare and state benefits.  
[Insert Table 3 and Fig. 2 around here] 
 
 
An examination of table 4 demonstrates our estimates of the aggregate costs of ADHD in 
adulthood for five countries. The calculations are carried out by simply taking the individual 
cost of ADHD and multiplying this by the prevalence rate of ADHD from a recent meta-
analysis[32]  and by the country’s recorded population in the age group between 18 and 65 
years. The aggregate costs presented in Table 4 are crude estimates and vary for four reasons. 
First, the costs vary across countries due to different demographic profiles within the various 
adult populations. Second, the costs vary due to the application of different reported 
prevalence rates. Third, the costs vary as a function of different ways of estimating total 
costs. Finally the between country comparison calculations based upon  two different sources, 
the Simons et al prevalence rate
32
 calculates prevalence rates of ADHD in adulthood that are 
unable to correct for diagnosis and access to care in childhood.  The Daley et al study 
31
 uses 
a prevalence rate of ADHD in adulthood, calculated using the prevalence of individuals who 
received a diagnosis of ADHD in Denmark, after their 18
th
 birthday.  Overall controlling for 
differences in prevalence, the cost data presented in table 4 suggest that adults who do not 
received a diagnosis until adult are a more disadvantaged group with higher costs that those 
who received a diagnosis in childhood and access to care The results in table 4 are presented 
in order to extend our findings to an international context. Doshi et al.[9] estimated the total 
cost of adult ADHD in the US at a magnitude of USD 105–194 billion. With a pooled 
prevalence for adult ADHD of 2.5% from a meta-analysis[32] we estimate a total cost of 
ADHD in the US of 99 billion euros. Using an average USD/EUR exchange rate of 1.27, this 
aggregate cost amounts to USD 126.2 billion, which is within the range reported by Doshi et 
al [9], albeit towards the lower end.  Our rather lower estimate is possibly due to the fact that 
we are able to control for a number of family characteristics and exclude the influence of co-
morbidity both of which will undoubtedly have elevated previous cost estimates. 
[Insert Table 4 around here] 
 Discussion 
This study has attempted to overcome the problem of unobserved heterogeneity, through 
conducting a same-sex sibling comparison, thereby estimating the true costs of ADHD as 
accurately as possible.  Findings from this study demonstrate that ADHD in adulthood is 
associated with considerable individual and public costs. Based on comparisons between 
adults with ADHD and their same-sex siblings, and removing any influence of comorbidity, 
the study has eliminated many of the shortcomings of previous cost studies. When compared 
to their siblings, adults with ADHD incurred much higher private and social costs. The results 
confirm existing findings that the cost burden of ADHD in adulthood in terms of medical 
costs, productivity and income losses[9]
 
are substantial, but unlike previous studies can be 
explained by ADHD in the individual rather than other social or environmental explanations. 
This study also confirmed the additional cost burden of ADHD on medication costs[9], but 
also on general practice[2], and in and out-patient hospital costs[10].  This study is one of the 
first to accurately estimate the additional contribution of crime, traffic accidents, and foster 
care to the overall costs associated with ADHD[9]. Although, our results show no significant 
difference for traffic and adult continuation of foster care. However, our results clearly 
demonstrate that costs associated with criminal activity among adults with ADHD were 
comparable to the costs associated with healthcare utilization and underlines the need to 
consider the wider economic impact of ADHD.  
 
The value of this study comes from the strength of the methodological approach and the use 
of the population based Danish Registers which allow for the identification of a large group 
of individuals with ADHD and a sibling comparison control. The ability to control for 
demographic differences allows an exploration of the unique costs associated with ADHD 
with little contamination from un-controlled variables. The study has extended previous 
findings by investigating a wider range of health and social outcomes and their combined 
costs to individuals and society. Despite the many strengths of this study there are important 
limitations to the analysis i) The Danish registers provide unique opportunities to investigate 
a comprehensive range of outcomes but are limited to direct, measurable outcomes, such as 
income and medication costs.  Registry studies do not allow the measurement of indirect 
costs, including the psychological burden, or perceived quality of life related to ADHD. ii) 
The applied cross-sectional cost analysis may not give a full picture of all costs over time. 
We have chosen to use a cross-sectional method as this method makes the best use of data 
and because the age of the group of adults with ADHD is too young to make good life-cycle 
estimates[30]. This choice implies that the obtained estimates represent a ‘snapshot of a 
moment in time’ and may not be a good estimate of costs in future years. iii) Data collected 
for the Danish registers are not research-led[33], which means that essential information for 
specific analyses may be missing. iv) While the study design was able to exclude the 
influence of treatment during childhood on costs, we were not able to control for the impact 
of treatment during adulthood, which may have lowered the cost estimates. v) Prevalence 
estimates indicate that clinical practice in Denmark is more conservative in diagnosing 
ADHD than in the USA[34]. Hence, the diagnosed sample in this study may represent a more 
severe and impaired group, which in turn may have impacted on the cost estimates. vi) 
Despite the many advantages of our sibling comparison design, it does exclude families with 
only one child from the analysis who may be different from families with siblings.  
Previous studies have underlined the considerable economic burden associated with ADHD. 
Yet, individual studies and systematic reviews point out inconsistency in costs associated 
with ADHD, with considerable variations in estimates. Secondly, several conceptual and 
methodological weaknesses in the current literature have been emphasized - especially in 
relation to the lack of focus on costs to societal systems such as welfare or criminal justice 
and the lack of adequate comparison groups.  This analysis has produced a more accurate 
methodology and a more confident estimate of the true economic impact of ADHD.  In 
comparison with other previous estimates and controlling for differences in national 
prevalence of ADHD, this study finds comparable costs, albeit it at the lower end of previous 
estimates, due no doubt to the ability remove the influence of comorbidity on cost as well as 
the opportunity to expand the cost estimate parameters to crime, traffic accidents and foster 
care costs.  
 
These results show the considerable costs associated specifically with ADHD and suggest 
that greater investment in earlier identification and treatment could be cost effective[35]. As 
ADHD involves costs in relation to a number of individual outcomes as well as for the public 
sector, effective strategies should be developed not only in the health sector but also include 
the education and employment sector to create a comprehensive evidence base for action in 
practice. The goal would be to facilitate sustainable outcomes for society and for individuals 
with ADHD.  
 
To conclude, ADHD diagnosed in adulthood presents with substantial costs for the individual 
and for society. We recommend that future research and health policy address the need for 
early identification and intervention strategies to mitigate the negative impact of ADHD in 
order to improve individual lives and reduce the costs associated with the disorder. Effective 
interventions addressing different areas of personal and social functioning hold the promise to 
increase opportunities for individuals with ADHD to attain optimal personal and social 
outcomes. 
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Table 1. Descriptions of ADHD subsamples and differences between study sample and the Danish adult population 
without psychiatric diagnoses. 
Groups 
Adults 
diagnosed 
with ADHD 
in 
adulthood 
Adults 
diagnosed 
with ADHD in 
adulthood, 
with no 
psychiatric 
comorbidity 
Adults diagnosed with 
ADHD in adulthood with 
a same sex sibling 
without psychiatric 
disorder 
Adult 
population 
without 
psychiatric 
disorders 
    Significance1  
Number of observations  5,269 1,553 460  3,049,195 
 
Demographic background      
Average age in 20102 30.0 29.2 31.7 *** 42.3 
Percentage male 63.8 67.2 67.2 *** 50.6 
Percentage of Danish origin 95.1 95.3 96.1 *** 90.8 
 
Labour market and income 
     Total annual income in 2010 (€) 23,809 23,870 26,259 ** 44,414 
Average annual wage income in 2010 (€)   7,312 10,678 12,545 *** 33,774 
Percentage wage employed in November 
2009 25.1 33.8 35.7 *** 70.1 
 
Educational attainment      
Percentage achieving 
primary/elementary education only, as 
of October 2010 68.8 67.0 62.6 *** 24.5 
Percentage with tertiary education as of 
October 2010 5.6 7.3 9.4 *** 29.6 
 
Health and health care utilization      
Average Spending on Medicine in 2010 
(€) 1,542 1,016 1,138 *** 190 
Average Number of Primary Care 
Services in 2010 26.5 21.4 22.0 *** 16.7 
Average Number of Secondary In-Patient 
Days in 2010  3.7 2.7 3.5  2.8 
 
Crime, Traffic, and respite care      
Percentage with criminal case in 2001-
2010 60.1 54.9 53.9 *** 20.6 
Table 1
Percentage who was a victim of a crime 
in 2001-2010 29.1 21.2 17.4 *** 7.6 
Percentage who had a Traffic Accident in 
2001-2010 8.4 6.6 5.7 *** 2.2 
Percentage who experienced 
foster/respite care as a child 14.7 13.4 8.9 *** 0.7 
 
Characteristics of parents      
Average Yearly Parental Income until 
18th birthday (€) 55,869 57,161 58,575 ** 63,587 
Percentage of Mothers achieving 
primary/elementary education, only 44.3 45.2 54.6 *** 39.8 
Percentage of Fathers achieving only 
primary/elementary education only 40.0 38.0 40.5 *** 29.7 
 
ADHD information      
Median year of diagnosis (50% 
percentile) 2009 2009 2009  - 
Average age at diagnosis 28.1 27.7 30.2  - 
Individuals prescribed ADHD medication 
during 1995-2010 (%) 85.5 85.5 85.2  - 
1 t-test for differences in mean between individuals with ADHD and siblings without comorbidity and all Danish 
Adults. Significance level: 0.10(*), 0.05(**), 0.01(***).  
2 We only explored diagnoses between 1995 and 2010, and while it is very unlikely, we cannot rule out the 
possibility that some of the included adults with ADHD, or their siblings, received a diagnosis in childhood prior to 
1995.  However, in the unlikely event that unobserved ADHD diagnosed in childhood and unobserved ADHD 
diagnosis for siblings occurred, this would imply that our cost estimates are conservative and it would reduce the 
cost differences between our groups. 
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Table 2:  Results from sibling comparison and unit cost 
 
 
Average for 
adults with 
ADHD 
Average for 
siblings 
Significance1 
Unit cost2 
€ 
Income and taxes        
Total employment income and public transfers, 
€ 26259.48 38251.75 **  
Income tax payments, € 6887.07 11406.21 **  
Public transfers 
   
 
 Social security and state benefits € 3113.44 465.75 **  
Early retirement benefits € 1945.28 888.01 **  
Student grants € 721.14 690.40 
 
 
Sickness benefits (number of days) 33.58 7.82 ** 72 
Education  
   
 
Secondary and vocational education 12.17% 12.39% 
 
 
Higher education 3.48% 6.74% * 10548 
Crime, traffic etc. (occurrences in 2010) 
   
 
Percentage who has been victim of a crime 2.83% 1.09% 
 
 
Percentage convicted of a crime: 
   
 
Violent crimes 5.65% 3.48% 
 
 
Burglary, theft and vandalism related crimes 11.96% 1.74% ** 2372 
Traffic related crime 10.43% 4.78% ** 1759 
Parentage who served time in prison 3.48% 0.87% * 25696 
Table 2
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Percentage who has been in a traffic accident - -   
Percentage who has been in adult continuation 
of foster care3 - -   
Health care utilisation 
   
 
Primary health care: 
   
 
Number of visits to their General Practitioner  15.47 8.18 ** 24.01 
Number of specialist appointments 2.49 1.43 ** 78.57 
Number of visits to a Psychologist 0.25 0.05 ** 63.99 
Number of other health related visits 3.77 5.41 * 34.34 
Secondary health care: 
   
 
Inpatients costs 703.93 497.27 
 
 
Outpatients costs 1207.44 413.74 **  
Medication: 
   
 
Patient costs of prescription medication, € 313.16 68.04 **  
Public subsidy to prescription medication, € 763.72 102.94 **  
Note: 460 siblings matched to their control siblings have been used. Numbers indicate values for 2010 unless 
otherwise noted. Source: Statistics Denmark. 
1Significance levels: * = p < 0.05, ** = p < 0.01.  
2 Unit cost of relevant, significant outcomes included in the costing analysis are shown 
3This estimation only concerns adult continuation of foster care whereas the numbers in Table 1 refer to the costs 
of childhood foster care 
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Table 3: Calculation of cost comparison using similar siblings, € per individual 
 
 
Adults with Siblings Cost Difference 
ADHD  € %3 
Individual or family borne costs     
 
Disposable income 
     
Total work income and public 
transfers 26,259 38,252 -11,992 -31% 
Income tax payment2 6,887 11,406 4,519 40% 
Other costs to the individual 
     
Patient cost of prescribed medication 313 68 -245 -360% 
Costs of being a victim of a crime 
  
0 N.A. 
 
Total cost to the individual     -7,718   
 
Public costs 
 
Public transfers and income tax         
   
Income replacement transfers 7,476 1,917 -5,559 -290% 
Income tax revenue to the state2 6,887 11,406 -4,519 -40% 
 
Crime, traffic, foster care and 
education 
     
Costs of being in a traffic accident1 
  
0 N.A. 
Costs of crimes committed 
(investigation, sentencing) 1,361 349 -1,012 -290% 
Education costs (direct costs) 367 711 344 48% 
Table 3
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Adult continuation of foster care1 
  
0 N.A. 
 
Medical expenses     
     
Secondary health care 1,207 414 -794 -192% 
Primary health care (GP and other 
primary care) 713 498 -215 -43% 
Public subsidy to prescribed 
medication  764 103 -661 -642% 
 
Total cost to the public sector     -12,416   
 
TOTAL COST (INDIVIDUAL + PUBLIC)     -20,134   
N.A.: Not applicable 
1 We found no statistical significant differences for traffic accidents and continuation of foster care 
2 The “income tax payment” listed under individual of family borne costs is repeated under “income tax 
revenue to the state” in the public costs part of the table (albeit with opposite signs). The lower “income 
tax payment” by “Adults with ADHD” reduces costs to the individual by €4,519, whereas the lower 
“income tax revenue to the state” by “Adults with ADHD” increases the public costs. The reason for this 
is that while “income tax payment” is a cost for the private individuals they represent a revenue of 
exactly the same magnitude to the public sector. Thus when aggregating, these two entries representing 
payment from one part of society to another cancels out and has no impact on the total costs, but needs 
to be included when looking at either the private individuals or the public sector separately. 
3 The cost difference in percent is calculated in relation to values for “Siblings”. 
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Table 4. Total cost to society (social cost) for individuals with ADHD for different countries (million €) 
 
 
Country Canada Denmark France Netherlands United Kingdom United States 
Adult population size (18-65 years) (N)      22,193,298         3,467,888       40,184,477       10,677,769       39,681,768     197,407,194  
  
Cost estimates based on present sibling-analysis, million € 
ADHD prevalence rate estimates   
Daley et al. (2015) 31 0.5% 2,439 381 4,417 1,174 4,361 21,697 
Simon et al (2009) 32 2.5% 11,171 1,746 20,227 5,375 19,974 99,365 
Table 4
 Fig 1:  Identification of dyads consisting of Adults with ADHD without psychiatric comorbidity and 
their siblings without any psychiatric disorder. 
Sample defined as A)Adults (18-65) in the Danish population in 2010, diagnosed in adulthood (18-50) 
from 1995-2010 and not in childhood: 5269 B)Adults (18-65) in the Danish population in 2010, 
diagnosed in adulthood (18-50) and  not in childhood with no other psychiatric diagnosis from 1995-
2010 (no age restriction): 1553 C) Adults (18-65) in the Danish population in 2010, diagnosed in 
adulthood (18-50) and not in childhood with a same sex (adult) sibling without any psychiatric 
diagnosis from 1995-2010 (no age restriction) or any history of ADHD medication from 1995-2010: N 
= 460. 
Figure 1
Fig 2: Infographic demonstrating relative cost differences in percentages between Adults 
with ADHD and their similar siblings 
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